1.780
0.00 (0.00%)
At close: Aug 8, 2025
CTI BioPharma Cash Flow Statement
Financials in millions AED. Fiscal year is January - December.
Millions AED. Fiscal year is Jan - Dec.
FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|
Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
---|
| -7.81 | -14.59 | -18.86 | -20.79 | -25.47 | |
Depreciation & Amortization | 2.86 | 2.86 | 2.82 | 2.91 | 3.46 | |
Loss (Gain) From Sale of Assets | -0.11 | -0.07 | - | - | -0.01 | |
Provision & Write-off of Bad Debts | 0.36 | 0.25 | 0.44 | 0.28 | 2.91 | |
Other Operating Activities | 0.46 | 2.22 | 2.3 | 0.12 | 0.87 | |
Change in Accounts Receivable | -4.46 | 4.18 | -1.09 | 16.28 | 129.58 | |
| -1.57 | 6.79 | 10.47 | 12.46 | -23.79 | |
Change in Accounts Payable | 2.06 | -8.05 | -3.05 | -0.48 | -37.43 | |
Change in Other Net Operating Assets | -11.19 | 36.71 | 13.32 | -16.01 | -46.76 | |
| -19.4 | 30.28 | 6.35 | -5.24 | 3.37 | |
Operating Cash Flow Growth | - | 376.80% | - | - | - | |
| -24.54 | -23.53 | -6.29 | -0.84 | -2.41 | |
Sale of Property, Plant & Equipment | 0.1 | 0.08 | - | - | 0.03 | |
| - | - | - | - | 0.37 | |
Sale (Purchase) of Intangibles | - | - | -0.01 | - | -0.07 | |
| -24.44 | -23.45 | -6.3 | -0.84 | -2.08 | |
| - | - | - | 9.37 | - | |
| 86.7 | 47.69 | - | - | - | |
| 86.7 | 47.69 | - | 9.37 | - | |
| - | - | -0.05 | -5.04 | - | |
| -34.73 | -52.56 | -0.49 | -0.54 | - | |
| -34.73 | -52.56 | -0.54 | -5.57 | - | |
| 51.97 | -4.87 | -0.54 | 3.8 | - | |
Other Financing Activities | 0.13 | -0.2 | -0.49 | -0.15 | -0.2 | |
| 52.1 | -5.07 | -1.03 | 3.64 | -0.2 | |
| 8.25 | 1.76 | -0.98 | -2.44 | 1.09 | |
| -43.94 | 6.75 | 0.06 | -6.08 | 0.96 | |
| - | 10887.99% | - | - | - | |
| -66.90% | 14.53% | 0.12% | -15.54% | 1.52% | |
| -0.16 | 0.02 | - | -0.02 | 0.00 | |
| 0.06 | 0.35 | 0.41 | 0.15 | 0.2 | |
| -36 | 12.09 | 5.89 | -0.31 | 57.71 | |
| -35.71 | 12.55 | 6.15 | 0.03 | 57.96 | |
Change in Net Working Capital | 9.34 | -41.99 | -21.29 | -12.82 | -72.75 | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.